Utah Medical Products, Inc. Extends Tender Offer

By ACCESS Newswire

SALT LAKE CITY, UT / ACCESS Newswire / October 5, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) is offering to purchase up to 650,000 shares of its common stock at $75.00 per share. The Offer was initially scheduled to expire at 5:00 p.m. New York City time, on Wednesday October 7. In order to allow all stockholders sufficient time to make their decisions, UTMD is extending the expiration date to 5:00 p.m. New York City time, on Tuesday October 27. The time extension provides the added benefit of allowing stockholders to consider UTMD's latest financial results for calendar 3Q 2026 which are scheduled to be announced on Thursday October 22.

Except for the extended expiration date, all the conditions of the Offer remain the same and are explained in detail by reference in the SEC Form TO-IA Offer to Purchase and Letter of Transmittal filed with the SEC at

https://www.sec.gov/Archives/edgar/data/706698/000109690626001481/0001096906-26-001481-index.htm

The Letter of Transmittal and certificates for Shares and any other required documents should be sent or delivered by each stockholder or his or her broker, dealer, commercial bank, trust company or other nominee to the Depositary at its address set forth below. The Depositary for the Offer is:

Computershare Trust Company, N.A.
P.O. Box 43011
Providence, RI 02940-3100
Attn: Voluntary Corporate Actions

Additional copies of the Offer to Purchase, the Letter of Transmittal or other tender offer materials may be obtained from the Information Agent and will be furnished at the Company's expense. Questions and requests for assistance concerning the Offer should be directed to the Information Agent:

Georgeson LLC
51 West 52nd Street, 6th Floor
New York, NY 10019
Call Toll Free: (866) 920-7258

Utah Medical Products, Inc., with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hundred countries around the world as the standard for obtaining optimal long-term outcomes for their patients. For more information about Utah Medical Products, Inc., visit UTMD's website at www.utahmed.com.

Contact:
Brian Koopman
(801) 566-1200

SOURCE: Utah Medical Products, Inc.



View the original press release on ACCESS Newswire

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.